drugset / Trial / NCT02426411
Dose Ranging Trial to Determine the Safety and Efficacy of EMA401 in Patients With PHN
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The study is a randomized, double blind, placebo-controlled, parallel-group comparison (two dose levels of EMA401 versus a placebo group), of safety and efficacy in patients with postherpetic neuralgia.
Timeline
- Start
- 2015-06
- Primary completion
- 2016-10
- Completion
- 2016-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | OLODANRIGAN | Small molecule | 100 mg | — |
| Subject | OLODANRIGAN | Small molecule | 300 mg | — |